65,437 trials
Respiratory Syncytial Virus Infection
Primary: RSV Season 1: Number of Participants With Respiratory Syncytial Virus (RSV)-Associated Medically Attended Lower Respiratory Infection (MALRI) — 60; 74 Participants…
Heart Failure
Primary: Changes in Exercise Capacity. — 14.0; 13.7 ml/min/kg — p=0.3
Satisfaction · Compassion Fatigue · Communication, Social
Primary: Job Satisfaction-Short Scale — 17.70; 14.10 score on a scale
Cardiac Arrest
Primary: Attrition — 0; 0 Participants
Hemophilia A
Primary: Number of Participants Who Discontinued the Use of Study Drug — 10; 5 Participants
Obesity · Life Style · Lifestyle, Sedentary
Primary: Primary Outcome — 68.18; 68.18; 70.45; 50 score on a scale — p=0.24
Other Cancer
Primary: Feasibility Based on Proportion of Subjects Enrolled — 60 Participants
Depressive Symptoms
Primary: Change in Self-report Measure of Depressive Symptoms — 13.90; 13.43; 7.00; 7.57 score on PHQ-9
Parkinson Disease
Primary: Adherence: Percentage of Sessions Completed — 38.0; 94.6 percent sessions completed
Opioid Use · Enhanced Recovery After Surgery · Anesthesia
Primary: Length of Stay — 5.0; 5.0 days
Hypertension
Primary: Change in Mean Sitting Diastolic Blood Pressure (DBP) Between Visit 2 (Week 0) and Visit 4 (Week 8) — -15.2 mmHg — p=<0.001
Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
Primary: Number of Participants Who Achieved Complete Remission (CR) or Complete Remission With Incomplete Hematological Recovery (CRi) Following Treatment With InO — 19…
Follicular Lymphoma · Marginal Zone Lymphoma · Mantle Cell Lymphoma
Primary: Number of Grades 3, 4, and/or 5 Dose-limiting Toxicities (DLT) Probably and/or Definitely Related to Triplet Combination Therapy — 0; 2; 0; 0 Adverse events
Allergic Rhinitis Due to House Dust Mite
Primary: Change From Baseline to the End-of-treatment Period in the Area Under the Curve of the Rhinitis Total Symptom Score Recorded During 4 Hours (0-4h) of the Allergen…
Femoral Neck Disease
Primary: Visual Analogue Scale（VAS） — 3.0; 4.0 score